Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
62,912,484
-
Total 13F shares
-
64,741,585
-
Share change
-
+3,209,655
-
Total reported value
-
$952,995,859
-
Put/Call ratio
-
9.7%
-
Price per share
-
$14.72
-
Number of holders
-
159
-
Value change
-
+$51,470,754
-
Number of buys
-
90
-
Number of sells
-
65
Institutional Holders of MACROGENICS INC - Common Stock (MGNX) as of Q1 2024
As of 31 Mar 2024,
MACROGENICS INC - Common Stock (MGNX) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,741,585 shares.
The largest 10 holders included
Bellevue Group AG, Avoro Capital Advisors LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., Frazier Life Sciences Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, ARMISTICE CAPITAL, LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
159
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.